Autonomic Dysfunction and Risk Factors Associated with Trypanosoma cruzi Infection among Children in Arequipa, Peru by Bowman, Natalie M. et al.
85
Am. J. Trop. Med. Hyg., 84(1), 2011, pp. 85–90
doi:10.4269/ajtmh.2011.10-0303
Copyright © 2011 by The American Society of Tropical Medicine and Hygiene
 INTRODUCTION 
 Chagas disease affects an estimated 8 million people and 
causes more morbidity and mortality in Latin America than 
any other parasitic disease, including malaria. 1, 2 In Perú, an 
estimated 192,000 people are infected with  Trypanosoma 
cruzi and 0.5 million residents of the city of Arequipa live 
in triatomine-infested districts, with potential risk of  T. cruzi 
infection. 1 Acute  T. cruzi infection usually causes detectable 
parasitemia and mild, nonspecific symptoms, and it resolves 
spontaneously over 4–8 weeks. 3 Infected persons then enter 
the chronic phase of infection, with the majority remaining in 
the indeterminate form characterized by positive serology but 
no signs or symptoms. Up to 30% of infected individuals even-
tually progress to cardiac disease, with manifestations rang-
ing from asymptomatic conduction abnormalities to lethal 
arrhythmias and dilated cardiomyopathy. Death may occur 
from congestive heart failure, ventricular arrhythmias, or high-
grade heart block, and it is often sudden. 4 Predictors of mor-
tality in established cardiomyopathy include congestive heart 
failure, left ventricular systolic dysfunction on echocardiogra-
phy, ventricular tachycardia, low QRS voltage, and male sex. 5– 7 
However, there are no known indicators to predict which 
infected individuals will progress to cardiomyopathy. 
 Characteristic electrocardiogram (EKG) abnormalities, 
including right bundle branch block, left anterior hemiblock, 
and ventricular extrasystoles, are the most common early signs 
of Chagas cardiomyopathy and have been reported in other-
wise asymptomatic  T. cruzi -infected adults and children. 8– 10 In 
studies in Brazil in the 1980s, 11–14% of seropositive children 
had EKG abnormalities, most frequently right bundle branch 
block, supporting the notion that cardiac damage begins early 
in the disease process. 8, 9 Another early abnormality is para-
sympathetic dysfunction, usually manifested by blunting of 
the normal heart rate and blood pressure responses to deep 
breathing, Valsalva maneuver, orthostatic stress, and other 
stimuli. 11– 15 Vagal denervation is thought to play an impor-
tant pathogenic role in gastrointestinal Chagas disease, and 
abnormal responses on autonomic stimuli were strongly asso-
ciated with the digestive form of the disease in one study. 16, 17 
However, the contribution of autonomic dysfunction to the 
pathophysiology of Chagas cardiomyopathy is less well-
defined, and its significance in the absence of other cardiac 
findings is controversial. 18, 19 
 Although risk factors for  T. cruzi infection have been stud-
ied in a number of rural settings, there are few data from urban 
foci of transmission. 20– 24 Our group’s investigations in periur-
ban Arequipa showed increased risk of triatomine infestation 
associated with domestic animals, unplastered house walls, 
and animal pens, and showed the highest prevalence of human 
 T. cruzi infection to be located on the densely populated hill-
sides outside the city. 25, 26 In the present analysis, we examined 
risk factors for  T. cruzi infection and compared EKG find-
ings and four tests of parasympathetic autonomic function in 
infected children and matched uninfected control children. 
 METHODS 
 Study design and objectives.  The study was designed as a 
matched case-control study to examine risk factors for  T. cruzi 
infection and investigate electrocardiographic and autonomic 
findings in  T. cruzi -infected children (cases) and uninfected 
controls. 
 Study site and population.  The study site and participants 
are described in detail elsewhere. 25– 27 Most study children were 
recruited in public schools in periurban communities on the 
outskirts of Arequipa; 20% were recruited at their homes in 
Guadalupe, a community within the larger study area. We stud-
ied children, because most were born and likely infected with 
Arequipa, providing a better indicator of local transmission. 
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 Ethical approvals and informed consent.  The protocol was 
approved by the Institutional Review Boards of Johns Hopkins 
University Bloomberg School of Public Health, Centers for 
Disease Control and Prevention (CDC), Peruvian National 
Institutes of Health, and Asociación Benéfica PRISMA. 
The parents of all participants provided informed consent; 
participants 7 years or older provided informed assent before 
the study began. For parents or participants unable to read, 
the form was read aloud, and consent or assent was indicated 
by fingerprint. 
 Serosurvey data collection.  Age, sex, and place of residence 
were recorded for each child. A 5-mL blood sample (3 mL 
for children under 5 years) was drawn. Blood was separated 
by centrifugation, and serum and cells were stored at −20°C 
in separate aliquots. Sera were screened for antibodies to 
 T. cruzi with a commercial enzyme-linked immunosorbent 
assay (ELISA ; Chagatek, Biomerieux, Marcy l’Etoile, France). 
The positive cutoff was set as 0.100 optical density (OD) units 
above the average OD of the negative control samples following 
instructions included in the kit. All positive samples and 10% of 
negative samples were tested by immunofluorescent antibody 
test (IFA) at CDC using a titer of 1:32 as the positive cutoff. 28 
Specimens positive by both ELISA and IFA were considered to 
have confirmed  T. cruzi infection. 29 Children positive by ELISA 
but negative by IFA were considered to have inconclusive 
results and were excluded from further analysis. 
 Clinical and cardiac studies.  All children with confirmed 
 T. cruzi infection were invited to participate in the case-control 
study. Two uninfected children were chosen at random, matched 
by age (±3 years), sex, and neighborhood of residence, to act 
as controls. Alternate control children were also chosen and in 
some cases, underwent testing. When there were insufficient 
numbers of uninfected children meeting the matching criteria 
in a given community, controls were drawn from the closest 
town with similar geographic and entomological features. 
 Each participant underwent a structured medical his-
tory and noninvasive physical examination by a trained local 
study physician (G.G.-C.). A 12-lead EKG was performed on 
each participant using a portable Fukuda Cardiosuny 501B-
III model EKG machine. Trained physicians and nurses per-
formed the following tests of autonomic function: (1) deep 
breathing (breathing deeply and slowly, one breath approxi-
mately every 10 seconds, for 1 minute), (2) Valsalva (perform-
ing the Valsalva maneuver for 15 seconds by blowing against 
a closed mouthpiece made of a small cup followed by nor-
mal breathing for 45 seconds), (3) cold pressor (immersing 
one hand in ice water up to the wrist for 1 minute), and (4) 
orthostatic (actively moving from a lying to standing position; 
a tilt table was not used). The duration of each test was 1 min-
ute; the participant rested at least 5 minutes before the first 
test and before each subsequent test. Testing was performed 
in the order described above for all patients. All tests were 
performed in the supine position unless otherwise noted, and 
children remained supine during the rest periods. Continuous 
EKG recording was conducted throughout all tests using lead 
II (or another limb lead if lead II was poor quality). Heart 
rate and blood pressure were recorded at baseline, 15 seconds 
(Valsalva and orthostatic), 30 seconds (deep breathing and 
cold pressor), and 1 minute. All clinical examinations, EKGs, 
and autonomic tests were performed at the local health posts. 
All seropositive children also underwent echocardiography 
at the Hospital Honorio Delgado in Arequipa. Parents were 
encouraged to be present for all of the child’s examinations. 
After collection of baseline clinical data, infected children 
were referred to the Ministry of Health for directly observed 
treatment with benznidazole for 60 days (10 mg/kg per day 
for children less than 10 years old; 5–7 mg/kg per day for chil-
dren 10–15 years old). 30 Children were monitored by Ministry 
of Health physicians throughout treatment to assess for side 
effects of the medication. 
 Risk factor data collection.  Risk factor data were collected 
for all consenting  T. cruzi -infected children. Because of 
resource constraints, one control child per case was chosen at 
random from among the matched control children included 
in the clinical component. The study team visited the homes 
of each child. Data were collected concerning previous travel 
and places of residence, medical and family history, housing 
construction material, and number and types of domestic 
animals. Entomological data collected during vector control 
activities were provided by the Arequipa Ministry of Health. 
 Data analysis.  EKG and autonomic studies were read and 
coded by two cardiologists blinded to the infection status of the 
participant; disagreements were resolved by a third physician 
with experience reading EKGs of patients with Chagas disease. 
The third reader categorized some EKGs as borderline, which 
was defined as abnormal but possibly normal variant and with 
no typical changes of Chagas disease; these were analyzed 
as abnormal studies. Statistical analysis was performed with 
STATA 8.0 (College Park, MD) and SAS 9.0 (Cary, NC). 
Univariate conditional logistic regression for matched samples 
was used to analyze clinical differences between groups and 
risk factors for  T. cruzi infection. Continuous variables were 
compared with paired  t test. Variables associated with  P value 
less than 0.2 in univariate analyses were included in a stepwise 
backwards elimination process to construct the multivariable 
model. No variable pair with correlation coefficient greater 
than 0.4 was included in the same model. 
 RESULTS 
 Clinical, electrocardiographic, and autonomic findings.  The 
serosurvey included 1,615 children, of whom 75 were confirmed 
seropositive for  T. cruzi . 25, 26 A total of 200 of these children 
(68 infected and 132 uninfected) took part in the case-control 
study; 54 (79%) cases had two matched controls, whereas nine 
cases had only one control and five cases had three controls. 
Case and control children did not differ by age, sex distribution, 
heart rate, blood pressure, or body mass index for age ( Table 1 ). 
No children had a history of rheumatic fever, arrhythmia, 
asthma, or diabetes, and no abnormalities were detected on 
cardiac examinations. A total of 39 children reported being 
hospitalized at least one time, most commonly for bone 
fractures or respiratory infections. However, one infected child 
had been hospitalized for Chagas disease, and two control 
children had been hospitalized for lymphocytic leukemia. 
 EKG data were available for 67 case and 126 control children. 
Compared with control children, infected children had a lower 
prevalence of sinus arrhythmia (physiological heart rate varia-
tion with respiration), longer corrected QT intervals (QTc), 
and higher prevalence of left anterior hemiblock, but none 
of these differences reached statistical significance ( Table 2 ). 
Seropositive children underwent echocardiography as part 
of the clinical assessment recommended by the Ministry of 
Health. Of 65 echocardiograms, only one was abnormal, with 
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mild hypertrophy of the interventricular septum and posterior 
left ventricular wall. This child’s EKG was normal, except for 
a prolonged QTc interval of 0.46 and a back-rotated axis con-
sistent with the echocardiographic findings. 
 Infected children showed blunted responses in several 
autonomic tests ( Table 3 ). Compared with control children, 
 T. cruzi -infected children had statistically significantly lower 
ratios of longest to shortest RR interval for the Valsalva 
maneuver, cold pressor, and orthostatic tests. Infected children 
also showed statistically significantly smaller mean change in 
systolic blood pressure at 15 and 60 seconds into the Valsalva 
maneuver than control children. There was a trend in the same 
direction for heart rate and blood pressure responses in the 
cold pressor and orthostatic tests, but these did not reach sta-
tistical significance. There was no association found between 
autonomic dysfunction and EKG abnormalities. 
 Risk factors for infection by  T. cruzi .  Risk factor data were 
collected for 138 children (68 cases and 70 controls); one case 
and three controls lacked a match, yielding a total for this 
analysis of 67 cases and 67 controls. There were 34 female and 
33 male pairs; the average age was 11.8 years (range = 6.12–
19.6 years). Infected children were significantly more likely 
to report the presence of triatomines in the home or having 
been bitten by a triatomine ( Table 4 ). Additional variables 
associated with  T. cruzi infection included having a household 
member previously diagnosed with Chagas disease, parents 
born outside of the province of Arequipa, signs of triatomine 
infestation (feces on the wall or shed exoskeletons) in the 
child’s room, the presence of animals in the home, especially 
in the child’s bedroom, and the use of loose stone or woven 
mats in household walls. The presence of fully plastered walls 
in the home was protective against infection. Documented 
capture of triatomines in the house or peridomestic area 
during Ministry of Health vector control activities was not 
significantly associated with infection. In multivariable model, 
three variables were significantly associated with increased risk 
of infection: reporting a relative or household member with 
Chagas disease, the presence of dead triatomines or triatomine 
feces in the child’s bedroom at the time of interview, and an 
animal sleeping in the child’s room at night ( Table 5 ). 
 DISCUSSION 
 The most interesting finding in our data was consistent blunt-
ing of cardiovascular autonomic responses in  T. cruzi -infected 
children compared with their matched controls. Ours are the 
first such data for children with chronic  T. cruzi infection, but 
similar findings have been reported in infected adults. 13– 15, 31 
 Table 1 
 Characteristics of 68 case children with confirmed  T. cruzi infection 
and 131 uninfected control children in Arequipa, Peru 
Characteristic
 T. cruzi -infected children 
( N = 68)
Uninfected children 
( N = 131) *  P 
Median age in years 
(range)
11.6 (6.1–16.4) 11.4 (6.0–15.8) 1.000
Male  n (%) 34 (50%) 65 (49.6%) 0.561
Mean heart rate (range) 77.8 (62–92) 78.6 (62–100) 0.240
Mean systolic blood 
pressure (range)
97 (80–130) 95.7 (60–120) 0.681
Diastolic blood 
pressure (range)
64.5 (50–80) 63.0 (38–80) 0.650
BMI for age < −2  Z 
scores † 
0 1 (0.89%) 1.000
 *  One control was lacking physical examination data. 
 †  Body mass index for age  Z scores based on the World Health Organization Child Growth 
Standards. 
 BMI = body mass index. 
 Table 2 
 Electrocardiographic findings in 67 children with confirmed  T. cruzi 
infection and 126 uninfected control children 
EKG finding
 T. cruzi -infected 
children ( N = 67) * 
Uninfected children 
( N = 126) *  P 
Any EKG abnormality 17 (25.37%) 33 (26.19%) 0.786
Sinus arrhythmia † 4 (5.97%) 20 (15.87%) 0.086
Low voltage 2 (2.99%) 4 (3.17%) 0.886
QRS axis +48.85 +52.67 0.311
Right-axis deviation 6 (9.23%) 6 (5.26%) 0.258
Left-axis deviation ‡ 6 (8.96%) 16 (12.70%) 0.326
Any conduction defect 6 (8.96%) 8 (6.35%) 0.451
PR interval in milliseconds 135 131 0.875
First-degree AV block 1 (1.49%) 1 (0.79%) 1.00
QRS interval (milliseconds) 76 78 0.992
Corrected QT interval 
(milliseconds)
424 370 0.158
Prolonged corrected QTc 
interval § 
14 (20.90%) 22 (17.46%) 0.678
Left anterior hemiblock 3 (4.48%) 2 (1.59%) 0.175
Left posterior hemiblock 0 3 (2.38%) 1.00
 *  One case child and five control children were missing EKG data. 
 †  Sinus arrhythmia defined as observed variability in heart rate with respiration. 
 ‡ Axis deviation was scored based on age-related data in Peruvian children. 46  
 §  Corrected QT interval was calculated using the formula QTc = QT/Ö(60/heart rate). 
 AV = atrioventricular. 
 Table 3 
 Results of four tests of autonomic nervous system function in 67 case 
children and 126 matched control children 
Autonomic test
 T. cruzi -infected 
children ( N = 67) * 
Uninfected children 
( N = 126) *  P 
Deep breathing test




Mean ratio of longest to 
shortest RR interval
1.575 1.645 0.013
Mean change in HR from 
0 to 15 seconds † 
+11.21% +12.85% 0.292
Mean change in HR from 
15 to 60 seconds
−16.14% −17.35% 0.307
Mean change in SBP from 
0 to 15 seconds ‡ 
+6.69% +9.42% 0.011
Mean change in SBP from 
15 to 60 seconds
−5.04% −7.01% 0.034
Cold pressor test
Mean ratio of longest to 
shortest RR interval
1.322 1.377 0.003
Mean change in HR from 
0 to 60 seconds
−1.03% +1.96% 0.031
Mean change in SBP from 
0 to 30 seconds
+4.69% +7.20% 0.015
Mean change in SBP from 
0 to 60 seconds
+8.26% +11.49% 0.019
Orthostatic test
Mean ratio of longest to 
shortest RR
1.464 1.560 0.000
Mean change in HR from 
0 to 15 seconds
+11.37% +14.07% 0.065
Mean change in HR from 
15 to 60 seconds
−5.89% −6.71% 0.756
Mean change in SBP from 
0 to 15 seconds
+3.21% +5.16% 0.252
Mean change in SBP from 
15 to 60 seconds
−1.64% −3.74% 0.117
 *  One case child and four control children were missing autonomic examination data; the 
respective control for the infected child was also excluded from this analysis. 
 †  HR = heart rate; 0 seconds signifies pretest value. 
 ‡  SBP = systolic blood pressure. 
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Because the absolute differences in performance on the auto-
nomic tests between groups were small and all children were 
well, we cannot interpret the clinical significance of this find-
ing. Pathological studies of Chagas disease show marked para-
sympathetic denervation, both in human autopsy specimens 
and animal models. 32 The neuronal damage is thought to occur 
during the acute phase of the infection and is presumed to be 
permanent. 12 The occurrence of autonomic dysfunction in chil-
dren as well as adults is consistent with this hypothesis. What 
is less clear is how autonomic dysfunction relates to the patho-
genesis of Chagas cardiomyopathy. 12, 19 Some investigators 
postulate that these are independent phenomena. 17 Because 
this study was not longitudinal in design and none of our sub-
jects had any evidence of clinically significant cardiac dysfunc-
tion, we could not draw any conclusions about the relationship 
between autonomic abnormalities and the development of 
Chagas cardiomyopathy. Although we found no association 
between autonomic test results and EKG findings, we found 
few EKG abnormalities and may have lacked the statistical 
power to detect such an association. 
 In contrast to earlier studies showing a substantial preva-
lence of conduction system disease in infected children in 
highly affected areas, 8, 9 we found no significant difference in 
the prevalence of EKG abnormalities between seropositive 
and seronegative children. Indeed, we found a low frequency 
of the conduction system abnormalities (right bundle branch 
block and left anterior hemiblock) and ventricular arrhyth-
mias typical of Chagas disease in our case children. This find-
ing may reflect lower intensity of parasite exposure, lower 
parasite burdens, and/or strain differences in Arequipa com-
pared with other study sites. The lower infection prevalence in 
Arequipa suggests a lower force of infection compared with 
study sites in Brazil, Argentina, or Bolivia, 33– 36 whereas the rel-
atively flat age prevalence curve supports the hypothesis that 
the parasite was only introduced into the periurban communi-
ties of Arequipa in the early 1990s. 26 Investigators have shown 
that repeated infection increases cardiac pathology in animal 
models 37, 38 and have suggested that vector control, by decreas-
ing reinfection rates, may be responsible for the milder disease 
now seen in formerly endemic communities. 39 Similarly, the 
children in our study may have had few repeated infections 
after their initial exposure. Another hypothesis, not mutually 
exclusive, is that the  T. cruzi strain in Arequipa is less virulent 
than strains found in other parts of South America. Our pre-
vious work shows that the immunological responses to whole 
epimastigote lysate and recombinant antigens are substan-
tially lower than in specimens from Bolivia. 40 
 The risk factors that we identified for urban transmission of 
Chagas disease were quite similar to those found in rural epide-
miological studies. 20, 22, 41 Not surprisingly, household members’ 
reports of triatomine infestation as well as traces of triatomine 
exuvia or feces in the child’s room were very strong predic-
tors of infection. However, household infestation rates based 
on bugs collected by the Ministry of Health spray teams were 
not strongly associated with the child’s risk of infection. Heavy 
infestation was associated with increased risk in studies in 
Argentina, and vector density was shown previously to be an 
independent risk factor for infection in children in Guadalupe 
(one community within the current study area). 25, 41 Reports 
from families and the presence of triatomine exuviae and 
feces may preferentially indicate heavier infestations, which 
more strongly elevate the risk of  T. cruzi infection. Other risk 
factors for  T. cruzi infection in the child included the reported 
presence of Chagas disease in a relative or household member, 
a factor that could reflect both shared exposures and the pos-
sible role of the infected household member as a reservoir of 
the parasite. 
 In studies from Argentina, the presence of dogs was strongly 
associated with infection risk. 20– 24 In our data, the presence of 
a dog per se did not significantly increase risk of infection; the 
majority of households owned dogs. However, allowing an ani-
mal to sleep in the child’s bedroom was associated with signifi-
cantly increased  T. cruzi risk; this factor was associated with 
increased bedroom vector infestation in our earlier analysis. 25 
Building materials, in particular those used in the child’s room, 
also altered the risk of  T. cruzi . In Arequipa, most shantytown 
homes are built of basalt stones, brick, or sillar that are either 
stacked or held together with cement and corrugated metal 
or brick roofs. Cracks in the walls and unmortared bricks 
increased risk, whereas plastering the walls and ceiling with 
stucco was protective, presumably by decreasing triatomine 
hiding places and eliminating crevices protected from insec-
ticide application. 25, 42 
 Our study had a number of limitations. Risk factor studies 
for  T. cruzi suffer unavoidably from the chronic character of 
 Table 4 
 Risk factors for  T. cruzi infection based on univariate conditional 
logistic regression of data from 67  T. cruzi -infected children and 67 
matched control children 
Odds ratio (95% 
confidence interval)  P 
Family characteristics
Mother born outside Arequipa 4.0 (1.5–10.7) 0.006
Father born outside Arequipa 3.4 (1.3–9.2) 0.016
Both parents born outside Arequipa 5.3 (1.8–15.3 0.002
Relative or household member with 
Chagas disease
17 (2.6–127) 0.006
Entomological characteristics of the home
Any triatomines captured in house or 
yard * 
1.2 (0.6–2.3) 0.613
Any triatomines captured inside house * 1.1 (0.57–2.2) 0.732
Risk per additional vector captured in 
house or yard * 
1.0 (0.97–1.1) 0.304
Risk per additional vector captured 
inside house * 
1.1 (0.97–1.2) 0.163
Triatomines in house † 16.5 (2.2–123) 0.006
Child bitten by triatomine † 18.1 (4.3–76) < 0.001
Characteristics of child’s room
Dead triatomines or triatomine feces 20 (2.7–149) 0.003
Plastered ceiling 0.36 (0.12–1.1) 0.083
Cracks in the walls or ceiling 2.00 (0.75–5.3) 0.166
Dog sleeps in room 3.3 (0.9–12.1) 0.067
Cat sleeps in room 2.8 (0.9–8.6) 0.083
Any animal sleeps in room 3.8 (1.2–11.3) 0.019
 *  Based on routine Ministry of Health vector collection at the time of indoor residual insec-
ticide application. 
 †  Reported by respondent in study interview. 
 Table 5 
 Risk factors for infection with  T. cruzi based on a multivariable condi-
tional logistic regression model of 67 matched case-control pairs 
Odds ratio 
(95% confidence interval)  P 
Relative or household member with 
Chagas disease
16.2 (0.7–357) 0.077
Dead triatomines or triatomine feces 
in child’s bedroom
44.2 (3.2–612) 0.005
Any animal sleeps in child’s bedroom 14.8 (1.4–162) 0.027
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this infection: the factors measured now may not indicate the 
situation 5 or 10 years ago when children were initially infected. 
The youngest study children were not always able to perform 
some of the autonomic tests, particularly, deep breathing and 
Valsalva maneuver, exactly to directions; the Valsalva maneu-
ver might also have been better standardized if a pressure 
gauge mouthpiece had been available. Most tests were done 
in the afternoon after school, but a proportion was performed 
in the morning, introducing the possibility of diurnal variation 
and differences in food and caffeine intake, which may have 
affected hemodynamic measures and autonomic responsive-
ness. Furthermore, there are few data describing autonomic 
function in healthy children, and normal limits have never 
been defined; our study may be the largest pediatric group 
with autonomic testing reported to date. Finally, our data are 
cross-sectional and therefore, cannot address the question of 
the prognostic value of autonomic dysfunction to predict the 
development of cardiomyopathy. 
 Our risk factor data highlight the importance of house-
hold insecticide application programs to interrupt domestic 
vector-borne transmission of  T. cruzi . Long-term success will 
require surveillance for and effective responses to reinfesta-
tion. 43 Meanwhile, advice to keep animals from sleeping in 
bedrooms and appropriate location-specific housing improve-
ments may help to decrease infestation and infection risk. 
Targeted screening strategies may improve the efficiency of 
programs to detect infected children and facilitate early treat-
ment. 27 Antitrypanosomal drug treatment is indicated for all 
 T. cruzi infected individuals younger than 18 years, with a 
recent trend to treat adults as well, 44, 45 introducing important 
ethical considerations when considering the possibility of lon-
gitudinal cohort studies to investigate the prognostic value of 
autonomic dysfunction to predict development or progression 
of cardiomyopathy. 
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